Disease on EC 3.4.24.B7 - matrix metalloproteinase-26
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Aggressive Periodontitis
Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis.
Ameloblastoma
Immunohistochemical expression of matrilysins (MMP-7 and MMP-26) in ameloblastomas and adenomatoid odontogenic tumors.
Astrocytoma
High MMP-26 expression in glioma is correlated with poor clinical outcome of patients.
Breast Neoplasms
Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness.
Breast Neoplasms
Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells.
Breast Neoplasms
Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.
Breast Neoplasms
Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
Breast Neoplasms
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Breast Neoplasms
Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
Breast Neoplasms
Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer.
Breast Neoplasms
Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.
Breast Neoplasms
Roles of matrix metalloproteinase-26 in the growth, invasion and angiogenesis of breast cancer.
Carcinogenesis
Estrogen and estrogen receptor induce matrix metalloproteinase-26 expression in endometrial carcinoma cells.
Carcinogenesis
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Carcinogenesis
Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis.
Carcinogenesis
Matrix metalloproteinases 21 and 26 are differentially expressed in esophageal squamous cell cancer.
Carcinoma
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
Carcinoma
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Carcinoma
Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells.
Carcinoma
Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.
Carcinoma
Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin.
Carcinoma
Effects of Detergents on Catalytic Activity of Human Endometase/Matrilysin-2, a Putative Cancer Biomarker.
Carcinoma
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma.
Carcinoma
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
Carcinoma
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Carcinoma
Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis.
Carcinoma
Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Carcinoma
Matrix metalloproteinases 21 and 26 are differentially expressed in esophageal squamous cell cancer.
Carcinoma
Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin.
Carcinoma
Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.
Carcinoma, Ductal
Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
Carcinoma, Ductal
Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
Carcinoma, Endometrioid
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
Carcinoma, Intraductal, Noninfiltrating
Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
Carcinoma, Intraductal, Noninfiltrating
Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
Carcinoma, Merkel Cell
Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma.
Carcinoma, Non-Small-Cell Lung
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Non-small cell lung cancer invasion and metastasis promoted by MMP-26.
Carcinoma, Non-Small-Cell Lung
[Expression and clinical significance of matrix metalloproteinase-26 in non-small cell lung cancer.]
Carcinoma, Squamous Cell
Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Choriocarcinoma
Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3.
Colonic Neoplasms
Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer.
Colorectal Neoplasms
Matrilysin-2 expression in colorectal cancer is associated with overall survival of patients.
Endometrial Hyperplasia
Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
Endometrial Hyperplasia
[MMP-26 mRNA and estrogen receptor alpha co-expression in normal and pathological endometrium]
Endometrial Neoplasms
Estrogen and estrogen receptor induce matrix metalloproteinase-26 expression in endometrial carcinoma cells.
Endometrial Neoplasms
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
Endometrial Neoplasms
Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
Endometrial Neoplasms
Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
Endometrial Neoplasms
Selected immunohistochemical prognostic factors in endometrial cancer.
Endometrial Neoplasms
[Immunohistochemical markers expression in hysteroscopy and hysterectomy specimens from endometrial cancer patients: comparison]
Esophageal Squamous Cell Carcinoma
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Matrix metalloproteinases 21 and 26 are differentially expressed in esophageal squamous cell cancer.
Fibrosarcoma
Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin.
Gingivitis
Gingival Crevicular Fluid Matrix Metalloproteinase-25 and -26 Levels in Periodontal Disease.
Glioma
Expression of Matrix Metalloproteinase-26 promotes human glioma U251 cell invasion in vitro and in vivo.
Glioma
High MMP-26 expression in glioma is correlated with poor clinical outcome of patients.
Ischemic Stroke
Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke.
Kidney Neoplasms
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Lung Neoplasms
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Lung Neoplasms
[Expression and clinical significance of matrix metalloproteinase-26 in non-small cell lung cancer.]
Lymphatic Metastasis
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Lymphatic Metastasis
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Lymphatic Metastasis
Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma.
Lymphatic Metastasis
Matrilysin-2 expression in colorectal cancer is associated with overall survival of patients.
Lymphoma, B-Cell
[Expression and significance of MMP-26, TIMP-4 and MMP-9 in diffuse large B-cell lymphoma cells].
Lymphoma, Large B-Cell, Diffuse
[Expression and significance of MMP-26, TIMP-4 and MMP-9 in diffuse large B-cell lymphoma cells].
Lymphoma, Non-Hodgkin
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Melanoma
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Melanoma
Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor.
Melanoma
MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotype.
Neoplasm Metastasis
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Neoplasm Metastasis
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Neoplasm Metastasis
Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma.
Neoplasm Metastasis
Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma.
Neoplasm Metastasis
Matrilysin-2 expression in colorectal cancer is associated with overall survival of patients.
Neoplasm Metastasis
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
Neoplasm Metastasis
[Expression and significance of MMP-26, TIMP-4 and MMP-9 in diffuse large B-cell lymphoma cells].
Neoplasms
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
Neoplasms
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Neoplasms
Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells.
Neoplasms
Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.
Neoplasms
Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin.
Neoplasms
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor.
Neoplasms
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Neoplasms
Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer.
Neoplasms
Effects of Detergents on Catalytic Activity of Human Endometase/Matrilysin-2, a Putative Cancer Biomarker.
Neoplasms
Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
Neoplasms
Evidence for a Proapoptotic Role of Matrix Metalloproteinase-26 in Human Prostate Cancer Cells and Tissues.
Neoplasms
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Neoplasms
Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3.
Neoplasms
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma.
Neoplasms
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
Neoplasms
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Neoplasms
Expression of Matrix Metalloproteinase-26 promotes human glioma U251 cell invasion in vitro and in vivo.
Neoplasms
Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor.
Neoplasms
Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip.
Neoplasms
Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma.
Neoplasms
Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis.
Neoplasms
Matrilysin-2 expression in colorectal cancer is associated with overall survival of patients.
Neoplasms
Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
Neoplasms
Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
Neoplasms
Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
Neoplasms
Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets alpha1-antitrypsin serpin.
Neoplasms
Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
Neoplasms
Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Neoplasms
Matrix metalloproteinases 21 and 26 are differentially expressed in esophageal squamous cell cancer.
Neoplasms
Maturation of growth differentiation factor 15 in human placental trophoblast cells depends on the interaction with Matrix Metalloproteinase-26.
Neoplasms
Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin.
Neoplasms
Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.
Neoplasms
Roles of matrix metalloproteinase-26 in the growth, invasion and angiogenesis of breast cancer.
Neoplasms
[Expression and clinical significance of matrix metalloproteinase-26 in non-small cell lung cancer.]
Neoplasms, Squamous Cell
Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis.
Ovarian Neoplasms
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma.
Ovarian Neoplasms
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Pancreatic Neoplasms
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Peri-Implantitis
Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis.
Periodontal Diseases
Gingival Crevicular Fluid Matrix Metalloproteinase-25 and -26 Levels in Periodontal Disease.
Plasmacytoma
Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis.
Pre-Eclampsia
Divergent changes in the content and activity of MMP-26 and TIMP-4 in human umbilical cord tissues associated with preeclampsia.
Prostatic Neoplasms
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
Prostatic Neoplasms
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor.
Prostatic Neoplasms
Evidence for a Proapoptotic Role of Matrix Metalloproteinase-26 in Human Prostate Cancer Cells and Tissues.
Prostatic Neoplasms
Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells.
Prostatic Neoplasms
Peaking of MMP-26 and TIMP-4 marks invasive transition in prostate cancer.
Prostatic Neoplasms
The Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer Cells.
Prostatitis
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
Pyoderma Gangrenosum
Expression of MMP-9, MMP-10 and TNF-alpha and lack of epithelial MMP-1 and MMP-26 characterize pyoderma gangrenosum.
Uterine Hemorrhage
Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
html completed